Literature DB >> 12662426

Efficacy of chloroquine in the treatment of uncomplicated, Plasmodium falciparum malaria in Niamey, Niger, in 2001.

F Dugelay1, E Adehossi, S Adamou, I Ousmane, D Parzy, J Delmont, P Parola.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12662426     DOI： 10.1179/00349803125002760

Source DB:  PubMed          Journal:  Ann Trop Med Parasitol        ISSN： 0003-4983


× No keyword cloud information.
  5 in total

1.  Ex vivo responses of Plasmodium falciparum clinical isolates to conventional and new antimalarial drugs in Niger.

Authors:  Mariama Issaka; Adamou Salissou; Ibrahim Arzika; Julia Guillebaud; Abani Maazou; Sabine Specht; Halima Zamanka; Thierry Fandeur
Journal:  Antimicrob Agents Chemother       Date:  2013-04-22       Impact factor: 5.191

2.  Epidemiological, clinical and biological features of malaria among children in Niamey, Niger.

Authors:  Françoise Gay-Andrieu; Eric Adehossi; Véronique Lacroix; Moussa Gagara; Maman Laminou Ibrahim; Hama Kourna; Hamadou Boureima
Journal:  Malar J       Date:  2005-02-09       Impact factor: 2.979

3.  Low Prevalence of Pfcrt Resistance Alleles among Patients with Uncomplicated Falciparum Malaria in Niger Six Years after Chloroquine Withdrawal.

Authors:  Adamou Salissou; Halima Zamanka; Brigitte Biyghe Binze; Taiana Rivière; Magalie Tichit; Maman Laminou Ibrahim; Thierry Fandeur
Journal:  Malar Res Treat       Date:  2014-11-23

4.  Field-based evidence of fast and global increase of Plasmodium falciparum drug-resistance by DNA-microarrays and PCR/RFLP in Niger.

Authors:  Maman Laminou Ibrahim; Nicolas Steenkeste; Nimol Khim; Hadiza Hassane Adam; Lassana Konaté; Jean-Yves Coppée; Fredéric Ariey; Jean-Bernard Duchemin
Journal:  Malar J       Date:  2009-02-23       Impact factor: 2.979

5.  Polymorphism of PfATPase in Niger: detection of three new point mutations.

Authors:  Maman Laminou Ibrahim; Nimol Khim; Hassane Hadiza Adam; Frédéric Ariey; Jean-Bernard Duchemin
Journal:  Malar J       Date:  2009-02-18       Impact factor: 2.979
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.